Skip to main content
Equibles
HTFL logo

HTFL · Heartflow, Inc.

Track HTFL — free

Use HTFL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about HTFL

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$47.78 -0.32 (-0.67%)
Russell 2000 member Rebalance outlook locked
Market Cap
$4.18B
Shares
86.95M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$48.10 Open$48.92 Day$48.03–50.44 52W close$20.49–50.20 Avg vol 30d1.8M Short int6.8M · 7.8% float · 3.9d Short vol35% Last earningsAug 13, 2026 DataAug 2025–Aug 2026 Filing10-Q · Aug 13

Up next

Next earnings call
Nov 12, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.5 · calm Equity put/call 0.39
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +64%
      above
      Price vs 50-day avg +50%
      above
      RSI (14) 79
      overbought
      MACD trend Positive
      52-week position 93%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +86%
      trailing
      6-month return +109%
      trailing
      YTD return +65%
      this year
      Relative strength +95%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $32 › 200d $29 — 50d above 200d
      Institutional flow Accumulating
      +14% holders QoQ · +51 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      7.80% of float · ▼ -1.0% MoM · 3.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      192 holders — near 1-yr high, broad support
      Squeeze score 63
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +40%
      Y/Y
      Gross margin 77%
      expanding
      EPS growth +82%
      Y/Y
      Free cash flow $-59.0M
      Balance sheet $44.8M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 81%
      annualized · 1-yr
      Max drawdown −49%
      past year
      ATR 5.1%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Aug 13, 2026
      full year 2026
      Non-GAAP gross margin Non-GAAP Raised 82%
      May 14, 2026 81% changed to Aug 13, 2026 82%
      Total revenue Raised $246M – $250M
      May 14, 2026 $228M – $232M changed to Aug 13, 2026 $246M – $250M
      prior FY $176.03M midpoint +40.9% Y/Y
      Full-year non-GAAP gross margin Non-GAAP Raised 82%
      May 14, 2026 81% changed to Aug 13, 2026 82%
      FLAG-specific revenue Initiated $29M – $31M
      2026
      Gross margin 82%
      Prior guidance period ended · from the Earnings Call filed Sep 30, 2025
      Full year 2025 revenue · full year 2025 $173M – $173.5M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +64% Bullish
      Price vs 50-day avg
      +50% Bullish
      RSI (14)
      79 Bearish
      MACD trend
      Positive Bullish
      52-week position
      93% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $32 › 200d $29 — 50d above 200d
      Institutional flow Accumulating
      +14% holders QoQ · +51 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      7.80% of float · ▼ -1.0% MoM · 3.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      192 holders — near 1-yr high, broad support
      Price context
      position in its 52-week range
      Range low $20 Now $48 · 93% Range high $50
      vs 200-day avg +64% vs 50-day avg +50%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Percentage of U.S. revenue cases attributable to office and clinic-based accounts 36% the three months ended June 30, 2026 filing —
      Revenue cases 84,491 Q2 2026 filing —
      GAAP → non-GAAP reconciliation
      GAAP Gross profit $42.16M
      +$166K Stock-based compensation expense
      = Non-GAAP Gross Profit $42.33M
      Gross margin non-GAAP 77% Year Ended December 31, 2025 —
      Loss from operations non-GAAP -50.1M Year Ended December 31, 2025 —
      GAAP → non-GAAP reconciliation
      GAAP Loss from operations -$64.07M
      +$13.97M Total adjustments
      = Loss from operations -$50.1M
      Net loss non-GAAP -59.88M Year Ended December 31, 2025 —
      GAAP → non-GAAP reconciliation
      GAAP Net loss -$116.79M
      +$56.91M Stock-based compensation expense, change in fair value of common stock warrant liability, change in fair value of derivative lia
      = Net loss -$59.88M
      Net loss per share, basic and diluted non-GAAP -$1.62 Year Ended December 31, 2025 —
      GAAP → non-GAAP reconciliation
      GAAP Net loss per share, basic and diluted -$3.17
      +$1.55 Total adjustments
      = Net loss per share, basic and diluted -$1.62
      U.S. installed base 1,465 as of December 31, 2025 —
      U.S. Plaque installed base 489 as of December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      HTFL
      Heartflow, Inc.
      this stock
      		$4.18B +65.0% +39.9% — 7.8%
      VEEV
      Veeva Systems Inc
      		 $39.78B +26.4% +28.1% 40.2 3.6%
      PMDIY
      Pro Medicus Ltd./ADR
      		 $13.02B -24.9% — — 0.0%
      TEM
      Tempus AI, Inc.
      		 $12.36B +19.7% +83.4% — 16.6%
      BTSG
      BrightSpring Health Services, Inc.
      		 $12.25B +62.6% +28.2% 37.5 4.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      192
      % held
      86.1%
      Net QoQ
      +9.8M sh
      Top holder
      Bain Capital Life Science…
      Held Float
      View
      Held by Funds
      Fund positions
      221
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      6.8M
      Days to cover
      3.9d
      Change
      -67.8K sh
      View
      Short Volume
      Short vol %
      35%
      As of
      Aug 27, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      4.0K
      Value
      $102.7K
      As of
      Jul 22, 2026
      View
      Off-Exchange
      Off-exchange %
      48.9%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $176.0M
      Net income (FY)
      $-116.8M
      EPS diluted
      $-3.17
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 13, 2026
      This year
      10
      View
      Proposed Sales
      Value
      $1.4M
      Shares
      27.2K
      Filed
      Aug 21, 2026
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Sep 9, 2026
      Last call
      Aug 13, 2026
      View
      Investor Relations
      Latest news
      Heartflow to Participate in the W…
      Published
      Aug 27, 2026
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      HTFL +2.8% +86.2% +109.3% +90.7% +65.0%
      SPY +1.1% +4.0% +14.7% +3.2% +13.1%
      vs SPY +1.7% +82.3% +94.6% +87.4% +51.9%
      Key facts CIK 1464521 CUSIP 42238D107 13F (30d) 173 filings 171 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)